Inovio Pharmaceuticals partners with GeneOne Life Science for MERS immunotherapy
Inovio Pharmaceuticals announced it will advance its DNA vaccine for MERS into a phase I clinical trial in healthy volunteers in a collaboration with GeneOne Life Science, an international DNA vaccine developer and manufacturer in which Inovio holds an equity interest. May 27, 2015